Antihypertensive activity of different components of Veratrum alkaloids through metabonomic data analysis.

Abstract

BACKGROUND:

Hypertension is a serious global public health issue. Blood pressure (BP) is still not effectively controlled in about 20 - 30% of hypertensive patients. Therefore, it is imperative to develop new treatments for hypertension. Veratrum alkaloids were once used for the clinical treatment of hypertension, the mechanism of which is still unclear. It was gradually phased out due to adverse reactions.

PURPOSE:

This study aimed to investigate the short-term and long-term hypotensive profiles of different components of Veratrum alkaloids in spontaneously hypertensive rats (SHRs) to unveil their mechanisms of action.

RESULTS:

Total Veratrum alkaloid (V), component A (A), and veratramine (M) quickly decreased BP within 30 min of treatment, reduced renal and cardiovascular damage, and improved relevant biochemical indicators (nitric oxide [NO], endothelin-1 [ET-1], angiotensin II [Ang II)], noradrenaline [NE], etc) in SHRs to delay stroke occurrence. Thereinto, A exhibited excellent protective effects in cardiovascular disease. The metabolomic profiles of SHRs treated with V, A, and M were significantly different from those of SHRs treated with vehicle. Thirteen metabolites were identified as potential pharmacodynamic biomarkers. Through Kyoto Encyclopedia of Genes and Genomes analysis, V, A, and M-induced hypotension was mainly related to alterations in nicotinate and nicotinamide metabolism, GABAergic synapses, linoleic acid metabolism, ketone body synthesis and degradation, arginine and proline metabolism, and urea cycle, of which nicotinate and nicotinamide metabolism was the key metabolic pathway to relieve hypertension.

CONCLUSION:

This work shows that A is an effective and promising antihypertensive agent for hypertension treatment to reduce BP and hypertensive target organ damage, which is mainly mediated through modulating nicotinate and nicotinamide metabolism, RAS, and NO-ET homeostasis.

• Authors: Zhaoli Zhou, Juan Chen, Yuzi Cui, Rihong Zhao, Hao Wang, Rui Yu, Tiantian Jin, Jinggong Guo, Yue Cong
• Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 120 Pg. 155033 (Nov 2023) ISSN: 1618-095X [Electronic] Germany
• PMID: 37647672 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved.

Chemical References

• Antihypertensive Agents
• Niacin
• Veratrum Alkaloids
• Niacinamide

Topics

• Humans
• Animals
• Rats
• Antihypertensive Agents (pharmacology)
• Niacin
• Veratrum Alkaloids
• Hypertension (drug therapy)
• Data Analysis
• Niacinamide